TENS / EMS DEVICE (FT-247 Series) (FT-247, FT-237)
Hivox Biotek, Inc. · Decision date Jun 16, 2026
What did the FDA decide?
FDA records K260425 as a 510(k) premarket notification, with a decision dated Jun 16, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Jun 16, 2026
Regulatory record facts
- Identifier
- K260425
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Hivox Biotek, Inc.
- Product code
- NUH
- Decision code
- SESE
- Decision date
- Jun 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, Nerve, Transcutaneous, Over-The-Counter.
- Applicant
- Hivox Biotek, Inc.
- Product code
- NUH
- FDA device class
- 2
FDA decision timeline
K260425 received
Application receipt date recorded by FDA.
K260425 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NUH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Hong Qiangxing (Shenzhen) Electronics Limited | 510(k) clearance | Oct 16, 2026 | FDA | |
| Shenzhen Osto Medical Technology Co.,Ltd | 510(k) clearance | Sep 6, 2026 | FDA | |
| Shenzhen Dongdixin Technology Co., Ltd. | 510(k) clearance | Jun 26, 2026 | FDA | |
TENS/EMS device (GUSE01)K253896 | Globalcare Medical Technology Co., Ltd. | 510(k) clearance | Mar 4, 2026 | FDA |
| Shenzhen Jiantuo Electronics Co., Ltd. | 510(k) clearance | Dec 31, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Hivox Biotek, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- New Taipei City
Sources and methodology
- Original FDA record: K260425
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


